Tag: Nasdaq:AMIX

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve-sensing and modulation, strengthening its strategic position in a multi-billion-dollar market opportunity and unlocking potential across cardiovascular, renal, and other high-burden diseases

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:AMIX

BTCS Inc. 当前所持 ETH 和现金市值已达 2.42 亿美元

Jia He Celebrates Singapore’s Diamond Jubilee with Exclusive Dining Experiences

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, TURN, STRM on Behalf of Shareholders

Tag: Nasdaq:AMIX

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us